About
RNAi Therapeutics
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapyChina
Clinical Trials (12)
View allTotal Trials
12
As Lead Sponsor
12
As Collaborator
0
Total Enrollment
337
By Phase
PHASE1/PHASE2: 4PHASE1: 5PHASE2: 3
By Status
COMPLETED: 9UNKNOWN: 1RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline12 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT05196373Lead Sponsor
Safety, Tolerability, Pharmacokinetics, Immunogenicity and Efficacy of STP705 in Adult Patients With Hypertrophic Scars
PHASE1/PHASE2Unknown
50 participants
Started: Jun 30, 2023 · Completed: Dec 31, 2024
NCT05844293Lead Sponsor
Single Ascending Dose of FXI-GalNAc-siRNA in Healthy Subjects
PHASE1Recruiting
40 participants
Started: May 16, 2023 · Completed: Jun 30, 2024
NCT05421013Lead Sponsor
Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Adults With Facial isSCC
PHASE1/PHASE2Completed
9 participants
Started: Aug 1, 2022 · Completed: Mar 29, 2023
NCT05422378Lead Sponsor
A Study to Evaluate Safety, Tolerability of Subcutaneous Injection in Adult Subjects Undergoing Abdominoplasty
PHASE1Completed
8 participants
Started: Aug 1, 2022 · Completed: Jun 27, 2023
NCT05309915Lead Sponsor
A Study of STP707 Administered by IV in Healthy Subjects
PHASE1Completed
20 participants
Started: Feb 28, 2022 · Completed: Aug 30, 2022
Locations (1)
Headquarters
Suzhou, China
Map
Loading map...